J Korean Ophthalmol Soc > Volume 58(3); 2017 > Article
Journal of the Korean Ophthalmological Society 2017;58(3):289-295.
DOI: https://doi.org/10.3341/jkos.2017.58.3.289    Published online March 15, 2017.
Treatment Outcome of Serous Macular Detachment in Circumscribed Choroidal Hemangioma.
Jeong Min Kwon, Seung Min Lee, Han Jo Kwon, Sung Who Park, Ji Eun Lee, Ik Soo Byon
1Research Institute for Convergence of Biomedical Science and Technology, Department of Ophthalmology, Pusan National University Yangsan Hospital, Yangsan, Korea. isbyon@pusan.ac.kr
2Medical Research Institute, Department of Ophthalmology, Pusan National University Hospital, Busan, Korea.
3Department of Ophthalmology, Pusan National University School of Medicine, Yangsan, Korea.
국한성 맥락막혈관종에서 발생한 장액망막박리에 대한 치료결과
권정민1⋅이승민1⋅권한조2⋅박성후2,3⋅이지은2,3⋅변익수1,3
양산부산대학교병원 안과학교실 의생명융합연구소1, 부산대학교병원 안과학교실 의생명연구소2, 부산대학교 의학전문대학원 안과학교실3
Correspondence:  Ik Soo Byon,
Email: isbyon@pusan.ac.kr
Received: 1 September 2016   • Revised: 25 January 2017   • Accepted: 1 March 2017
Abstract
PURPOSE
To determine the clinical outcome of anti-vascular endothelial growth factor (anti-VEGF) and photodynamic therapy (PDT) for circumscribed choroidal hemangioma (CCH) with serous retinal detachment. METHODS: The medical records of patients having CCH with serous retinal detachment in macula were retrospectively reviewed. CCH and serous retinal detachment were evaluated via fundus photography, optical coherence tomography, indocyanine green angiography, and ultrasonography. RESULTS: A total of 9 eyes were enrolled in this study. The average follow-up period was 19.2 months. The mean visual acuity was 0.51 ± 0.52 (logMAR) and the mean maximum diameter and thickness of the tumor were 6,154.4 ± 2,019.9 µm and 2,224.4 ± 862.1 µm, respectively. Of the 6 eyes receiving anti-VEGF (mean number of injections: 3.16) as the first treatment for serous retinal detachment, 5 had sustained or recurred intraretinal/subretinal fluid (IRF/SRF) and needed additional PDT and transpupillary thermotherapy. In the 3 eyes that received PDT (mean number of treatments: 1.3) as an initial treatment, IRF/SRF was completely resolved. Finally, 8 eyes achieved complete resolution of SRF and IRF; however visual recovery was limited. CONCLUSIONS: PDT, even with a small number of treatments, can alleviate IRF/SRF in CCH, while anti-VEGF did not.
Key Words: Circumscribed choroidal hemangioma;Serous retinal detachment;Photodynamic therapy


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next